Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab combinations in advanced gastric cancer
NCT06748508Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Dec 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib, paclitaxel in gastric cancer (GC), sponsored by Fudan University. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
lenvatinibpaclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT06748508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06748508.